Wird geladen...
Fabry nephropathy: a review – how can we optimize the management of Fabry nephropathy?
Fabry disease is a rare, X-linked, lysosomal storage disease caused by mutations in the gene encoding the enzyme alpha-galactosidase A. Complete or partial deficiency in this enzyme leads to intracellular accumulation of globotriaosylceramide (Gb(3)) and related glycosphingolipids in many cell types...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4029839/ https://ncbi.nlm.nih.gov/pubmed/24886109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-15-72 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|